| |
| |
|
| Insider
Information: |
Patou Gary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
37,714 |
|
|
Indirect Shares
|
5,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$18,322 |
|
|
| Total
Shares |
43,318 |
|
|
| Total
Value |
$18,322 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
14,141 |
2004-11-02 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2014-08-07 |
0 |
2014-08-07 |
702 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-14 |
4/A |
S |
$41.05 |
$311,898 |
I/I |
(7,598) |
4,902 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
S |
$41.05 |
$311,898 |
I/I |
(7,598) |
4,902 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
S |
$38.94 |
$447,085 |
D/D |
(11,380) |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
D |
$39.68 |
$119,913 |
D/D |
(3,022) |
27,550 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2023-12-13 |
4 |
OE |
$9.00 |
$137,487 |
D/D |
14,402 |
28,717 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
OE |
$2.68 |
$5,513 |
D/D |
2,057 |
25,630 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
D |
$34.37 |
$4,124 |
D/D |
(120) |
25,510 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
S |
$34.79 |
$67,390 |
D/D |
(1,937) |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-23 |
4 |
S |
$34.33 |
$70,610 |
D/D |
(2,057) |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-12-08 |
4 |
OE |
$3.67 |
$7,549 |
D/D |
2,057 |
25,630 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-03-17 |
4 |
A |
$19.49 |
$1,949 |
I/I |
100 |
100 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2020-10-28 |
4 |
OE |
$3.76 |
$7,734 |
D/D |
2,057 |
23,573 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-12-04 |
4 |
OE |
$3.56 |
$7,323 |
D/D |
2,057 |
21,516 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-12-14 |
4 |
OE |
$3.07 |
$6,315 |
D/D |
2,057 |
19,459 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-06-14 |
4 |
D |
$8.30 |
$23,705 |
D/D |
(2,856) |
17,402 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-06-14 |
4 |
OE |
$3.70 |
$30,451 |
D/D |
8,230 |
20,258 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-10 |
4 |
B |
$2.78 |
$20,836 |
I/I |
7,500 |
12,500 |
2.1 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-08 |
4 |
B |
$3.00 |
$15,003 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-12-06 |
4 |
D |
$7.90 |
$34,784 |
D/D |
(4,403) |
12,028 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-12-06 |
4 |
OE |
$3.21 |
$39,627 |
D/D |
12,345 |
16,431 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-11-04 |
4 |
D |
$8.32 |
$16,266 |
D/D |
(1,955) |
4,086 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-11-04 |
4 |
OE |
$5.22 |
$18,254 |
D/D |
3,497 |
6,041 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-01-07 |
4 |
OE |
$4.98 |
$17,415 |
D/D |
3,497 |
3,497 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-01-07 |
4/A |
D |
$22.28 |
$21,233 |
D/D |
(953) |
2,544 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2014-08-07 |
4 |
AS |
$100.26 |
$2,005,200 |
D/D |
(20,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
